Hydrogenated castor oil nanoparticles as carriers for the subcutaneous administration of tilmicosin: In vitro and in vivo studies

Journal of Veterinary Pharmacology and Therapeutics

Volumn 32, Issue 2, 2009, Pages 116-123

  Han, C ^a   Qi, C M ^a   Zhao, B K ^a   Cao, J ^a   Xie, S Y ^a   Wang, S L ^a   Zhou, W Z ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGENATED CASTOR OIL; SOLID LIPID NANOPARTICLE; SOLVENT; TILMICOSIN; WATER OIL CREAM;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG ELIMINATION; DRUG FORMULATION; ENCAPSULATION; EVAPORATION; HALF LIFE TIME; INJECTION SITE INFLAMMATION; MALE; MAXIMUM ALLOWABLE CONCENTRATION; MEAN RESIDENCE TIME; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SINGLE DRUG DOSE; SURFACE CHARGE; SUSTAINED DRUG RELEASE; TISSUE REACTION; TOXICITY TESTING;

ANIMALS; ANTI-BACTERIAL AGENTS; CASTOR OIL; CHROMATOGRAPHY, LIQUID; DRUG DELIVERY SYSTEMS; FEMALE; HALF-LIFE; HYDROGENATION; INFUSIONS, SUBCUTANEOUS; MALE; MICE; MICE, INBRED BALB C; NANOPARTICLES; RANDOM ALLOCATION; TOXICITY TESTS; TYLOSIN;

MUS;

EID: 61849135248     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2008.01009.x     Document Type: Article

References (22)

1. Bailey, R.W. Scott, E.G. (1970) Diagnostic Microbiology, 3rd edn, pp. 289 306. The C.V. Mosby Company, Saint Louis, USA.
2. Clark, C., Woodbury, M., Dowling, P., Ross, S. Boison, J.O. (2004) A preliminary investigation of the disposition of tilmicosin residues in elk tissues and serum. Journal of Veterinary Pharmacology and Therapeutics, 27, 385 387.
3. Jain, R., Shah, N.H., Malick, A.W. Rhodes, C.T. (1998) Controlled drug delivery by biodegradable poly(ester) devices: different preparative approaches. Drug Development and Industrial Pharmacy, 24, 703 727.
4. Jiang, H.Y., Ding, S.Y., Li, J.C., An, D.J. Shen, J.Z. (2006) Residue depletion of tilmicosin in cattle after subcutaneous administration. Journal of Agricultural and Food Chemistry, 54, 5208 5213.
5. Jordan, W.H., Byrd, R.A., Cochrane, R.L., Hanasono, G.K., Hoyt, J.A., Main, B.W., Meyerhoff, R.D. Sarazan, R.D. (1993) A review of the toxicology of the antibiotic MICOTIL 300. Veterinary and Human Toxicology, 35, 151 158.
6. McGuigan, M.A. (1994) Human exposures to tilmicosin. Veterinary and Human Toxicology, 36, 306 308.
7. Müller, R.H., Mäder, K. Gohla, S. (2000) Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. European Journal of Pharmaceutics and Biopharmaceutics, 50, 161 177.
8. Nickerson, S.C., Owens, W.E., Fox, L.K., Scheifinger, C.C., Shryock, T.R. Spike, T.E. (1999) Comparison of tilmicosin and cephapirin as therapeutics for Staphylococcus aureus mastitis at dry-off. Journal of Dairy Science, 82, 696 703.
9. Olbrich, C., Kayser, O. M̈uller, R.H. (2002) Enzymatic degradation of Dynasan 114 SLN-effect of surfactants and particle size. Journal of Nanoparticle Research, 4, 121 129.
10. Osaka, T.S., Hyogo, T.T. Osaka, Y.S. (1991) Sustained-Release Preparations and the Process Thereof, US patent No. 5,023,089.
11. Owens, W.E., Nickerson, S.C. Ray, C.H. (1999) Efficacy of parenterally or intramammarily administered tilmicosin or ceftiofur against Staphylococcus mastitis during lactation. Journal of Dairy Science, 82, 645 647.
12. Pan, B.L., Wang, Y.W., Pan, Z.D., Lifschitz, A.L. Wang, M. (2006) Pharmacokinetics of eprinomectin in plasma and milk following subcutaneous administration to lactating dairy cattle. Veterinary Research Communications, 30, 263 270.
13. Prabha, S., Zhou, W.Z., Panyam, J. Labhasetwar, V. (2002) Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. International Journal of Pharmaceutics, 244, 105 115.
14. Ramadan, A. (1997) Pharmacokinetics of tilmicosin in serum and milk of goats. Research in Veterinary Science, 62, 48 50.
15. Romtman, A. Blatt, Y. (1992) Heat Stabilized Flavoring Agents Coated with Hydrogenated Castor Oil, U.S. Patent 5,098,725.
16. Sahoo, S.K., Panyam, J., Prabha, S. Labhasetwar, V. (2002) Residual polyvinyl alcohol associated with poly (D, L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. Journal of controlled Release, 82, 105 114.
17. Scorneaux, B. Shryock, T.R. (1999) Intracellular accumulation, subcellular distribution, and efflux of tilmicosin in bovine mammary, blood, and lung cells. Journal of Dairy Science, 82, 1202 1212.
18. Shekunov, B.Y., Chattopadhyay, P., Seitzinger, J. Huff, R. (2006) Nanoparticles of poorly water-soluble drugs prepared by supercritical fluid extraction of emulsions. Pharmaceutical Research, 23, 196 204.
19. Song, Y.H., Bai, X.H. Li, Y. (2005) Determination of tilmicosin by ultraviolet spectrophotometry. Journal of Shanxi Medical University, 36, 71 73.
20. Van Donkersgoed, J., Dubeski, P.L., VanderKop, M., Aalhus, J.L., Bygrove, S. Starr, W.N. (2000) The effect of animal health products on the formation of injection site lesions in subprimals of experimentally injected beef calves. Canadian Veterinary Journal, 41, 617 622.
21. Wissing, S.A., Kayser, O. Müller, R.H. (2004) Solid lipid nanoparticles for parenteral drug delivery. Advanced Drug Delivery Reviews, 56, 1257 1272.
22. Ziv, G., Shem-Tov, M., Glickman, A., Winkler, M. Saran, A. (1995) Tilmicosin antibacterial activity and pharmacokinetics in cows. Journal of Veterinary Pharmacology and Therapeutics, 18, 340 345.